1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. AVALO THERAPEUTICS INC
Avalo Therapeutics Inc
XNAS: AVTX
18.44 0.68 (3.83%)
800.2K
XNAS Volume

XNAS 24 Jul, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Avalo Therapeutics Inc is on 29 Jul 2026 for the purpose of BTIG Biotechnology Conference See details

Avalo Therapeutics Inc - AVTX - stock price prediction, stock price target, analyst ratings from 15 analysts

Avalo Therapeutics Inc has a share price target of US$ 45 and profit growth estimate of -9.5% for Unknown Year, based on top 15 analyst calls.